The purpose of this study was to investigate the resistance and virulence markers in microbial strains isolated from the hospital environment, recovered after surfaces decontamination with quaternary ammonium compounds, triclosan, iodine disinfectants, in order to predict their role in healthcare-associated infections. The resistance phenotypes were established using disk diffusion and double-disk diffusion test. Simplex and multiplex PCR assays were used to identify the genetic support of cell-associated and soluble virulence factors The Gram-negative bacterial strains isolated from hospital surfaces after decontamination were resistant in high proportions to beta-lactam antibiotics, including penicillins and associations with beta-lactamase inhibitors, third and fourth generation cephalosporins and carbapenems (encoded by bla TEM , bla NDMlike bla CTX-Mlike , bla OXA-48like genes), quinolones (QnrA, gyrB, parE genes), aminoglycosides (aac3Ia gene), and tetracyclines. Regarding the virulence profiles, P. aeruginosa strains revealed the plcH gene (86.6%) followed by plcH, ExoS, algD and ExoU, while the Enterobacteriaceae strains, fimH (24%), followed by papC, sfaDE, hlyA, cnf1, eaea and VT2 genes. S. aureus isolates revealed the SCCmec cassette of type II (40%), followed by type V, IIIA and type IV (2B) and the clfA, clfB, and can adhesion genes. These findings demonstrate that incorrect practices in biocides use, regarding contact time and concentrations or instruments and surfaces insufficient cleaning before disinfection can decrease their effect and favor the persistence of resistant and virulent microbial strains in the hospital environment. The multiple drug resistance and virulence determinants, encoded by diverse genetic elements suggest the potential of these strains to persist and initiate hospital-associated infections.
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The continuously and increasingly emergence and spread of microbial resistance worldwide has led to the introduction of disinfection procedures based on widespread used biocides in hospital (instruments, various devices, surfaces and air) and food industry. However, despite their broad action, with multiple unspecific target sites at the level of microbial cell (e.g., cytoplasmic membrane, nucleic acids, fatty acids, proteins, enzymes), the efficacy of biocides can be affected by intrinsic factors, like: enzymatic degradation, permeability barrier, biocide concentration, contact time but also by acquired resistance mechanisms [1] [2] [3] . The bacterial cells grown in biofilms were found to be 150 to 3000 times more resistant to disinfectants, mainly due to poor penetration of the biofilm polysaccharide matrix [4, 5] . Although it has been demonstrated that the mutation is a rare mechanism for resistance acquisition to biocides, this was documented for triclosan (FAB I) [6] [7] [8] and quaternary ammonium compounds (qacG) resistance [9] [10] [11] .
Experimental part Bacterial strains and virulence analysis
A total number of 60 bacterial strains belonging to Escherichia coli (n=10), Klebsiella pneumoniae (n=15), * email: magda.mitache@yahoo.com
All authors have equal contribution to the study and the publication Pseudomonas aeruginosa (n=15) and Staphylococcus aureus (20) were recovered in 2016 from hospital surfaces after decontamination with quaternar y ammonium compounds, triclosan and iodine disinfectants in Public Health Diagnostic and Research Laboratory. The strains identification was performed with traditional biochemical tests and the automated miniApi system [12, 13] . The antibiotic susceptibility testing was performed using the disk diffusion method (Kirby-Bauer), following the CLSI recommendations (2015 and 2016 editions).
Molecular analysis
The genetic support of the resistance (carbapenemases, ESBLs, aminoglycosides and quinolones) and virulence in Gram-negative rods (table 1) was investigated by simplex and multiplex PCR, using a reaction mix of 20µL (PCR Master Mix 2x, Thermo Scientific) containing 1µL of bacterial DNA extracted using the alkaline extraction method (table 2). In this purpose, 1-5 colonies of bacterial cultures were suspended in 1.5 mL tubes containing 20 µL solution of NaOH (sodium hydroxide) and SDS (sodium dodecyl sulphate). The amplification program was runned on a PCR thermal Corbett machine. The genotypic characterization of the SCCmec cassette types in S.aureus strains was performed using simplex and multiplex PCR. Two reactions were performed using the multiplex PCR with five and four pairs of specific primers respectively for the various sequences of the SCCmec cassette. Their classification and parameters used to conduct the reactions followed the protocol developed by Miheirico et al. [14] and Zhang et al. [15] . The detection of the specific virulence genes was performed by three simplex PCR and three multiplex PCR assays according with previous published protocols [16] .
Results and discussions
P. aeruginosa strains isolated from hospital surfaces after decontamination were resistant in high proportions to ticarcillin (53.33%), third and fourth generation cephalosporins (ceftazidime=53.33% and cefepime= 46.66%), ciprofloxacin (33.33%), gentamicin (26.66%), carbapenems (imipenem and meropenem) (20%), piperacillin (20%), piperacillin+tazobactam (13.33%).
Regarding the antibiotic resistance genes our study revealed that 20% of the analyzed strains resistant to meropenem and imipenem produced imipenemase and 26.6% of the analyzed strains revealed the presence of blaTEM gene. No quinolone resistance genes were found in the investigated strains and only one isolate revealed the aac3Ia gene which confers aminoglycoside resistance. Concerning the virulence profiles of P. aeruginosa strains, the molecular analysis through PCR arrays showed that all the analyzed strains revealed the plcH gene, in 86.6% of the strains were found plcH, ExoS and AlgD genes and only 33.3% of P. aeruginosa harbored the ExoU gene. In P. aeruginosa strains, the plcH gene encodes for a phospholipase that promotes the degradation of the erythrocyte membrane, exposing the inner layer to PlcN that could then hydrolyze the phospatidylserine residues present on this level.
In 2016 Porumbel et al., revealed the presence of the both PlcH and PlcN genes in 27 MDR nosocomial strains isolated from hospitalized patients with primar y cardiovascular diseases, The presence of algD gene encoding for alginate production in the majority of tested strains demonstrates their possible involvement in infections with biofilm formation [29]; 18% of the analyzed strains expressed the ExoS gene -an anti-phagocytic factor which could affect eukaryotic cell cytoskeletal structure [30] and less frequently, the ExoU gene a highly virulence marker in P. aeruginosa isolates from hospitalacquired pneumonia [31] .
The E. coli and Klebsiella pneumoniae strains exhibited â-lactam [60% of the isolates were resistant to cefepime; 56% to piperacillin-tazobactam; 52% to ceftazidime; 40% to carbapenems (imipenem and meropenem) and 32% to amoxicillin-clavulanic acid and piperacillin]; aminoglycosides (52% of the strains were resistant to amikacin and 48% to gentamicin and tobramycin); quinolones (48% were resistant to ciprofloxacin); tetracyclines (56%) resistance. The results of PCR analysis for carbapenemases and ESBLs genes revealed the presence of bla NDMlike gene (28% of K. pneumoniae isolates and 20% of E.coli strains); bla CTX-Mlike gene in 28% of E.coli and 24% of K. pneumoniae isolates and bla OXA-48like gene only in 4% of the K. pneumoniae strains. The genetic findings suggest the possible nosocomial origin of the respective strains. The carbapenemases and ESBLs genes may reside within the same plasmids and, therefore, be spread together. Quinolone resistance was revealed by QnrA gene (16% of E.coli and 4% of K. pneumoniae); gyrB gene (25% of E.coli and 16% of K. pneumoniae); and parE gene (25% of E.coli isolates).
Regarding the virulence genes of the Enterobacteriaceae strains, our results have revealed the presence of fimH gene in the case of 24% of the investigated strains; papC and sfaDE (20%); hlyA and cnf1 genes (12%); eaea and VT2 genes (4%). The FimH gene encodes for type I fimbriae which are involved in the colonization of urinary tract, which may suggest a crucial role of this virulence gene in infections caused by E. coli [32] . Similar results were obtained. The study performed by Chelariu et al., in 2016 on 133 strains isolated from stool samples in patients with metabolic syndrome admitted in Cardiology and Internal Medicine Units of Hospital Prof. Ctin Angelescu also revealed the fimH as the most frequent virulence marker. The sfaDE gene represents an important adhesin of uropathogenic E. coli strains causing urinary tract infections in humans [33] and The HlyA is a poreforming toxin, which belongs to the family of RTX (repeats in toxin) toxins that are widespread among the Gramnegative pathogens [34] . In 2015, Grosu et al., also revealed in a high percent the expression of fimH virulence factor in E.coli strains isolated from urinary tract infections from the ambulatory sector of Central Laboratory Regina Maria Hospital in Bucharest, Romania from January to December 2014 [35] [36] [37] .
In S. aureus isolates the molecular analysis through PCR arrays showed that 40% of the isolates revealed the SCCmec cassette of type II, followed by type V and IIIA (30%) and type IV (2B) (20%). Regarding the virulence genes, the molecular analysis using PCR methods showed that 40% of the analyzed strains expressed both the clumping factor (clf) A and B genes and 50% of the isolates presented the collagen adhesin (cna) gene. The finding that, among the investigated S. aureus strains, the majority present adhesions, demonstrates that these strains have the potential to initiate an infectious process.
Conclusions
Incorrect practices in biocides use, regarding contact time and concentrations or instruments and surfaces insufficient cleaning before disinfection can decrease their effect and favor the persistence of resistant and virulent microbial strains in the hospital environment. Moreover, microorganisms can be incorporated in different organic substrata, like pus, blood, serum, food waste or may grow in biofilms, that may also impair the effect of disinfectants. Therefore, monitoring of biocides efficacy and resistance should be implemented as a key component of the hospital infections control strategies.
